Trial of octacosanol in amyotrophic lateral sclerosis
Norris, F.H.; Denys, E.H.; Fallat, R.J.
Neurology 36(9): 1263-1264
1986
ISSN/ISBN: 0028-3878 PMID: 3528918 Document Number: 274129
Octacosanol was tried in amyotrophic lateral sclerosis in a double-blind, placebo-controlled, crossover design. Neurologic and pulmonary function evaluations showed no benefit.
Document emailed within 1 workday
Related Documents
Alonso, K.; Medenica, R. 1995: Immunomodulation in the treatment of multiple sclerosis and amyotrophic lateral sclerosis: a model for autoimmune disorders Journal of the National Medical Association 87(8): 561-568Gallagher, J.P. 1986: Is it amyotrophic lateral sclerosis or something else? Journal of the South Carolina Medical Association 82(1): 19-22
Zavalishin, I.A.; Zakharova, M.N. 1999: Amyotrophic lateral sclerosis Zhurnal Nevrologii i Psikhiatrii Imeni S.S. Korsakova 99(4): 60-64
Bouche, P.; Castaigne, P.; Meininger, V. 1989: Management of amyotrophic lateral sclerosis Revue Neurologique (Paris) 145(1): 49-54
Bali, T.; Miller, T.M. 2013: Management of amyotrophic lateral sclerosis Missouri medicine 110(5): 417-421
Hirano, A. 1991: Cytopathology of amyotrophic lateral sclerosis Advances in Neurology 56: 91-101
1995: Riluzole for amyotrophic lateral sclerosis Medical Letter on Drugs and Therapeutics 37(963): 113-114
Lupo, V.R.; Rusterholz, J.H.; Reichert, J.A.; Hanson, A.S. 1993: Amyotrophic lateral sclerosis in pregnancy Obstetrics and Gynecology 82(4 Pt 2(Suppl): 682-685
Kuźma-Kozakiewicz, M.; Kwieciński, H. 2009: The genetics of amyotrophic lateral sclerosis Neurologia i Neurochirurgia Polska 43(6): 538-549
Vemireddi, N.K.; Crevoiserat, C.A. 1978: Amyotrophic lateral sclerosis in cancer Journal of the Mississippi State Medical Association 19(11): 201-204
Kurtzke, J.F. 1982: Epidemiology of amyotrophic lateral sclerosis Advances in Neurology 36: 281-302
Krutsay, M.; Jakubovits, E. 1993: Rapid course amyotrophic lateral sclerosis Orvosi Hetilap 134(40): 2209-2211
Barkhatova, V.P.; Zavalishin, I.A.; Kostiuk, A.V.; Demina, E.G.; Moskvitina, T.A. 1996: Neurotransmitter changes in amyotrophic lateral sclerosis Zhurnal Nevrologii i Psikhiatrii Imeni S.S. Korsakova 96(4): 78-85
Antel, J.P.; Noronha, A.B.; Oger, J.J.; Arnason, B.G. 1982: Immunology of amyotrophic lateral sclerosis Advances in Neurology 36: 395-402
Carter, G.T.; Miller, R.G. 1998: Comprehensive management of amyotrophic lateral sclerosis Physical Medicine and Rehabilitation Clinics of North America 9(1): 271-284 VIII-IX
Wachi, M.; Uehara, K.; Fujinaka, W.; Takatori, M.; Tada, K. 2011: Use of sugammadex in a patient with amyotrophic lateral sclerosis Masui. Japanese Journal of Anesthesiology 60(12): 1408-1410
Clavelou, P.; Guy, N. 2006: Symptomatic treatments in amyotrophic lateral sclerosis Revue Neurologique (Paris) 162(Special Issue 2): 4s228-4s234
Amico, L.L.; Antel, J.P. 1981: Amyotrophic lateral sclerosis: current concepts Postgraduate Medicine 70(2): 50-61
Averback, P. 1983: Virus cultures in amyotrophic lateral sclerosis Canadian Medical Association Journal 129(10): 1070-1071
Ramelli, E. 1970: Prognostic factors in amyotrophic lateral sclerosis Acta Neurologica 25(4): 441-449